Interesting news today re Mayne purchasing an $890 million chunk of Teva's drugs portfolio. Puts a bit more perspective on Teva's walk away? AB
- Forums
- ASX - By Stock
- Mayne Pharma
Interesting news today re Mayne purchasing an $890 million chunk...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.724B |
Open | High | Low | Value | Volume |
$1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5951 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 133644 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1376 | 1.665 |
1 | 13289 | 1.600 |
3 | 6122 | 1.595 |
4 | 18974 | 1.590 |
7 | 5111 | 1.565 |
Price($) | Vol. | No. |
---|---|---|
1.365 | 798 | 1 |
1.435 | 104 | 1 |
1.440 | 11142 | 1 |
1.450 | 10000 | 1 |
1.500 | 40716 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online